NSE:INDRAMEDCO Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	1,836	1,610	1,240	861.5	586.2
Depreciation & Amortization	436.3	438.7	394.6	378.4	332.7
Other Amortization	-	4.6	6.2	14.3	16.7
Loss (Gain) From Sale of Assets	5.3	5.2	11.7	8.7	57.7
Loss (Gain) From Sale of Investments	-11.4	-	-	-	-
Other Operating Activities	-292.1	-252.9	-205.2	115.2	-15.8
Change in Accounts Receivable	-319.1	-193.6	138.7	-234.9	259.5
Change in Inventory	-8.7	5.4	9.2	15.4	-12.5
Change in Accounts Payable	27.9	-49.8	406.7	286.1	-281.5
Operating Cash Flow	1,674	1,568	2,002	1,445	943
Operating Cash Flow Growth	6.82%	-21.68%	38.54%	53.20%	251.73%
Capital Expenditures	-596.5	-363.3	-693.9	-445.8	-294.8
Investment in Securities	11.4	-	-	-	-
Other Investing Activities	-1,191	-746.6	-890.4	-633.3	-446.3
Investing Cash Flow	-1,776	-1,110	-1,584	-1,079	-741.1
Long-Term Debt Repaid	-24.3	-21.3	-37.9	-28.3	-25.1
Total Debt Repaid	-24.3	-21.3	-37.9	-28.3	-25.1
Net Debt Issued (Repaid)	-24.3	-21.3	-37.9	-28.3	-25.1
Common Dividends Paid	-410.3	-407.3	-275.4	-228.4	-2.6
Other Financing Activities	-29.2	-30.2	-10.5	-3.7	-6
Financing Cash Flow	-463.8	-458.8	-323.8	-260.4	-33.7
Net Cash Flow	-565.5	-1.2	93.4	105.2	168.2
Free Cash Flow	1,078	1,204	1,308	998.9	648.2
Free Cash Flow Growth	-10.49%	-7.91%	30.90%	54.10%	1008.03%
Free Cash Flow Margin	7.27%	8.88%	10.51%	9.09%	7.30%
Free Cash Flow Per Share	11.76	13.14	14.26	10.90	7.07
Cash Interest Paid	29.3	30.3	10.6	4.6	6.1
Cash Income Tax Paid	669.2	609.8	468.3	98.5	195.1
Levered Free Cash Flow	684.04	1,177	1,139	956.2	606.55
Unlevered Free Cash Flow	721.66	1,196	1,146	959.08	610.36
Change in Working Capital	-299.9	-238	554.6	66.6	-34.5